Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Haeberlein

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
RSC Advances|January 13, 2025
Bis-3-chloropiperidines: a novel motif for anthelmintic drug designMichael Kirchner, Michael Marner, Tim Kramer, et al.
Archiv Der Pharmazie|September 15, 2021
Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivativesAlejandra M Peter Ventura, Simone Haeberlein, Leonie Konopka, et al.
International Journal for Parasitology|May 29, 2019
Identification of a new panel of reference genes to study pairing-dependent gene expression in Schistosoma mansoniSimone Haeberlein, Alexandra Angrisano, Thomas Quack, et al.
Chemmedchem|August 28, 2019
Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti-schistosomal ActivityAlejandra M Peter Ventura, Simone Haeberlein, Kerstin Lange-Grünweller, et al.
Frontiers in Immunology|February 21, 2018
Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of <i>Leishmania major</i>, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary <i>L. major</i> InfectionUlrike Schleicher, Jan Liese, Nicole Justies, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Toll-like receptor ligation for the induction of regulatory B cellsLuciën E P M van der Vlugt, Simone Haeberlein, Wouter de Graaf, et al.
Molecules (Basel, Switzerland)|February 25, 2022
Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against SchistosomiasisBernardo Pereira Moreira, Michael H W Weber, Simone Haeberlein, et al.
Archiv Der Pharmazie|December 9, 2022
From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activityTom L Gallinger, Wiebke Obermann, Kerstin Lange-Grünweller, et al.
European Journal of Medicinal Chemistry|August 26, 2022
Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effectsGeorg A Rennar, Tom L Gallinger, Patrick Mäder, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic CompoundsTom L Gallinger, Samuel Y Aboagye, Wiebke Obermann, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
RSC Advances|January 13, 2025
Bis-3-chloropiperidines: a novel motif for anthelmintic drug designMichael Kirchner, Michael Marner, Tim Kramer, et al.
Archiv Der Pharmazie|September 15, 2021
Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivativesAlejandra M Peter Ventura, Simone Haeberlein, Leonie Konopka, et al.
International Journal for Parasitology|May 29, 2019
Identification of a new panel of reference genes to study pairing-dependent gene expression in Schistosoma mansoniSimone Haeberlein, Alexandra Angrisano, Thomas Quack, et al.
Chemmedchem|August 28, 2019
Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti-schistosomal ActivityAlejandra M Peter Ventura, Simone Haeberlein, Kerstin Lange-Grünweller, et al.
Frontiers in Immunology|February 21, 2018
Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of <i>Leishmania major</i>, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary <i>L. major</i> InfectionUlrike Schleicher, Jan Liese, Nicole Justies, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 13, 2014
Toll-like receptor ligation for the induction of regulatory B cellsLuciën E P M van der Vlugt, Simone Haeberlein, Wouter de Graaf, et al.
Molecules (Basel, Switzerland)|February 25, 2022
Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against SchistosomiasisBernardo Pereira Moreira, Michael H W Weber, Simone Haeberlein, et al.
Archiv Der Pharmazie|December 9, 2022
From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activityTom L Gallinger, Wiebke Obermann, Kerstin Lange-Grünweller, et al.
European Journal of Medicinal Chemistry|August 26, 2022
Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effectsGeorg A Rennar, Tom L Gallinger, Patrick Mäder, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic CompoundsTom L Gallinger, Samuel Y Aboagye, Wiebke Obermann, et al.
Pageof 5